Status:

TERMINATED

A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD

Lead Sponsor:

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions:

Stress Disorders, Post-Traumatic

Eligibility:

All Genders

6-17 years

Phase:

PHASE3

Brief Summary

To evaluate the safety and efficacy of sertraline compared to placebo in children and adolescents (6 to 17 years of age) who are outpatients with Posttraumatic Stress Disorder.

Detailed Description

This study was terminated on July 11, 2007. The results of the primary endpoint analysis at the interim showed that the Zoloft group was not significantly different than the placebo on the primary end...

Eligibility Criteria

Inclusion

  • Subjects must be from 6 to 17 years of age and will have a maximum age of 17 at the Baseline Visit of the study.
  • Subjects must have a diagnosis of Posttraumatic Stress Disorder as defined by DSM-IV and determined by the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL).

Exclusion

  • Subjects whose trauma is ongoing, or who are living in the same home as their abuser, or who are expected to participate in litigation related to their trauma during the course of the study will be excluded from participation.
  • Subjects who are likely to or are at high risk for experiencing re-exposure to their index trauma.

Key Trial Info

Start Date :

November 1 2002

Trial Type :

INTERVENTIONAL

End Date :

July 1 2007

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT00150306

Start Date

November 1 2002

End Date

July 1 2007

Last Update

January 29 2021

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Pfizer Investigational Site

Scottsdale, Arizona, United States, 85281

2

Pfizer Investigational Site

Sacramento, California, United States, 95817

3

Pfizer Investigational Site

San Diego, California, United States, 92111

4

Pfizer Investigational Site

San Marcos, California, United States, 92078